Rusfertide reduces or eliminates phlebotomy needs in polycythemia vera, improving quality of life and symptom control. The VERIFY trial showed 77% clinical response with rusfertide, compared to 33% in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results